Getting it right from the beginning
Identifying, screening and qualifying investigative sites is an ongoing challenge for every clinical study. The more accurate the initial feasibility assessment, the more successful the study — leading to projects delivered on-time and completed within budget.
For each project a member of the clinical team is appointed to oversee the feasibility and is supported by a dedicated team of local CRAs to manage the kick-off in the individual countries. With over 25 years’ experience and a broad investigator network of Key Opinion Leaders (KOLs) & Principal Investigators, the team has access to a large pool of sites to involve in study feasibilities across a broad range of therapeutic indications.
The Feasibility Process
During the feasibility process the teams will
- Review the clinical trial protocol and design, carefully studying the various specific geographic regions, to assess whether the study is a good fit for a particular country or region
- Work with clinical sites and investigators to assess the level of interest in the clinical study, as well as to identify issues that may affect recruitment, execution and/or patient retention
- Review the competitive landscape to identify other clinical trials vying for the same or similar patient population
- Assess feedback from the investigators on inclusion and exclusion criteria, medication, study procedures, patient recruitment etc., which assists in the overall study strategy and protocol.